compound spotlight12 min
Dual-Receptor Agonism: What the Human Trials Actually Show
Tirzepatide and retatrutide are the most consequential metabolic compounds in a generation. Here is what the human data says, and what most people miss.
Read
The Journal
Compound spotlights, mechanism reviews, and the studies our protocol team is currently watching. Each piece anchored to peer-reviewed citations — no unsourced claims, no marketing spin.
research10 min
BPC-157 and TB-500: A Practical Read on the Tissue Repair Stack
Two of the most discussed peptides in recovery research, with the angles users actually report — including the ones that don't make it into the abstracts.
Read
compound spotlight11 min
The Growth Hormone Stack: CJC-1295 + Ipamorelin in Practice
What endogenous growth hormone pulse research tells us, what users report on body composition and sleep, and the angle most people miss about why this stack matters.
Read
longevity12 min
Mitochondrial Bioenergetics: The Three-Compound Longevity Stack
NAD+, SS-31, and MOTS-c — the cellular-energy research compounds with the strongest mechanistic stories. What the data supports, and the practical effect users notice first.
Read
compound spotlight10 min
Selank and Semax: The Russian Nootropic Peptides Worth Understanding
Two heptapeptides developed at the Russian Institute of Molecular Genetics — anxiolytic without sedation, nootropic without stimulation. Why the cognition research community has been paying attention.
Read
compound spotlight10 min
GHK-Cu: The Copper Tripeptide That Doesn't Behave Like a Cosmetic
GHK-Cu is the most-cited compound in dermatology research that hasn't crossed into mass-market skincare. The data is more interesting than the marketing.
Read
More compound spotlights in queue — monthly publishing cadence